Uterine volume (cm³) · women with premature ovarian insufficiency (POI) awaiting oocyte donation
2 findings from 1 review
Endometrial thickness (mm) · women with premature ovarian insufficiency (POI) awaiting oocyte donation
2 findings from 1 review
Endometrial histology · women with premature ovarian insufficiency (POI) awaiting oocyte donation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uterine perfusion · women with premature ovarian insufficiency (POI) awaiting oocyte donation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Reproductive outcomes · women with premature ovarian insufficiency (POI) awaiting oocyte donation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · women with premature ovarian insufficiency (POI) awaiting oocyte donation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · Women in the peri‐ or postmenopausal phase
2 findings from 1 review
Side effects: acne ‐ oral administration · Women in the peri‐ or postmenopausal phase
It is very uncertain whether oral DHEA changes side effects: acne ‐ oral administration compared with control subgrouped by differing routes of administration (very low certainty).
1 finding from 1 review
Frequency of hot flushes Oral beta‐estradiol 1.0 and 2.0 mg/day vs CEE 0.625 or 1.25 mg/day · women with hot flushes
1 finding from 1 review
Adverse events Oral beta‐estradiol 1.0 or 2.0 mg/day vs CEE 0.625 or 1.25 mg/day · women with hot flushes
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
Oral beta‐estradiol showed no clear difference in frequency of hot flushes Oral beta‐estradiol 0.5‐1.0 mg/day compared with placebo (low certainty).
1 finding from 1 review
Adverse effects Oral beta‐estradiol 0.5‐2.0 mg/day · women with hot flushes
1 finding from 1 review
Postoperative ileus · Women who had major abdominal gynaecologic surgery
Early oral feeding showed no clear difference in postoperative ileus compared with delayed oral feeding (moderate certainty).
1 finding from 1 review
Maternal nausea and/or vomiting · Women who had major abdominal gynaecologic surgery
Early oral feeding showed no clear difference in nausea or vomiting or both compared with delayed oral feeding (moderate certainty).
1 finding from 1 review
Time to bowel sounds [days] · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Time from completion of operation to first flatus (hours) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Postoperative time to solid diets (days) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Time to first BM (№ women with 1st BM on day 2 after delivery) · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Length of hospital stay · Women who had major abdominal gynaecologic surgery
1 finding from 1 review
Side effects: acne ‐ skin application · Women in the peri‐ or postmenopausal phase
It is very uncertain whether oral DHEA changes side effects: acne ‐ skin application compared with control subgrouped by differing routes of administration (very low certainty).
1 finding from 1 review